Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alessio Mazzoni

Showing results (61-70 of 75) with videos related to

Pageof 8
Sort By:
European Journal of Immunology|January 23, 2026
Downregulation of CD19 Expression Associates With Mantle Cell Lymphoma Relapse Following CAR-T Cell TherapyBenedetta Peruzzi, Alessio Mazzoni, Ilaria Cutini, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|February 21, 2024
Disseminated nocardiosis and anti-GM-CSF antibodiesBarbara Brugnoli, Lorenzo Salvati, Nicoletta Di Lauria, et al.
European Journal of Immunology|October 20, 2020
Cell-mediated and humoral adaptive immune responses to SARS-CoV-2 are lower in asymptomatic than symptomatic COVID-19 patientsAlessio Mazzoni, Laura Maggi, Manuela Capone, et al.
Journal of Clinical Immunology|July 2, 2022
Long-term SARS-CoV-2 Asymptomatic Carriage in an Immunocompromised Host: Clinical, Immunological, and Virological ImplicationsMichele Spinicci, Alessio Mazzoni, Marco Coppi, et al.
The Journal of Clinical Investigation|February 9, 2022
SARS-CoV-2 infection and vaccination trigger long-lived B and CD4+ T lymphocytes with implications for booster strategiesAlessio Mazzoni, Anna Vanni, Michele Spinicci, et al.
The Journal of Clinical Investigation|May 3, 2021
First-dose mRNA vaccination is sufficient to reactivate immunological memory to SARS-CoV-2 in subjects who have recovered from COVID-19Alessio Mazzoni, Nicoletta Di Lauria, Laura Maggi, et al.
Journal of Clinical Immunology|July 9, 2022
Clinical and Immunological Features of SARS-CoV-2 Breakthrough Infections in Vaccinated Individuals Requiring HospitalizationGiulia Lamacchia, Alessio Mazzoni, Michele Spinicci, et al.
Immunology Letters|June 21, 2024
Effect of antimetabolite regimen on cellular and humoral immune response to SARS-COV-2 vaccination in solid organ transplant recipientsManuela Capone, Anna Vanni, Lorenzo Salvati, et al.
Immunology Letters|December 16, 2024
Seasonal patterns of myositis-specific and myositis-associated autoantibodies in Italy: Seasonal patterns of myositis autoantibodiesBoaz Palterer, Alessio Mazzoni, Maria Infantino, et al.
The Journal of Clinical Investigation|May 29, 2020
Impaired immune cell cytotoxicity in severe COVID-19 is IL-6 dependentAlessio Mazzoni, Lorenzo Salvati, Laura Maggi, et al.
Pageof 8

Showing results (61-70 of 75) with videos related to

Sort By:
Pageof 8
European Journal of Immunology|January 23, 2026
Downregulation of CD19 Expression Associates With Mantle Cell Lymphoma Relapse Following CAR-T Cell TherapyBenedetta Peruzzi, Alessio Mazzoni, Ilaria Cutini, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|February 21, 2024
Disseminated nocardiosis and anti-GM-CSF antibodiesBarbara Brugnoli, Lorenzo Salvati, Nicoletta Di Lauria, et al.
European Journal of Immunology|October 20, 2020
Cell-mediated and humoral adaptive immune responses to SARS-CoV-2 are lower in asymptomatic than symptomatic COVID-19 patientsAlessio Mazzoni, Laura Maggi, Manuela Capone, et al.
Journal of Clinical Immunology|July 2, 2022
Long-term SARS-CoV-2 Asymptomatic Carriage in an Immunocompromised Host: Clinical, Immunological, and Virological ImplicationsMichele Spinicci, Alessio Mazzoni, Marco Coppi, et al.
The Journal of Clinical Investigation|February 9, 2022
SARS-CoV-2 infection and vaccination trigger long-lived B and CD4+ T lymphocytes with implications for booster strategiesAlessio Mazzoni, Anna Vanni, Michele Spinicci, et al.
The Journal of Clinical Investigation|May 3, 2021
First-dose mRNA vaccination is sufficient to reactivate immunological memory to SARS-CoV-2 in subjects who have recovered from COVID-19Alessio Mazzoni, Nicoletta Di Lauria, Laura Maggi, et al.
Journal of Clinical Immunology|July 9, 2022
Clinical and Immunological Features of SARS-CoV-2 Breakthrough Infections in Vaccinated Individuals Requiring HospitalizationGiulia Lamacchia, Alessio Mazzoni, Michele Spinicci, et al.
Immunology Letters|June 21, 2024
Effect of antimetabolite regimen on cellular and humoral immune response to SARS-COV-2 vaccination in solid organ transplant recipientsManuela Capone, Anna Vanni, Lorenzo Salvati, et al.
Immunology Letters|December 16, 2024
Seasonal patterns of myositis-specific and myositis-associated autoantibodies in Italy: Seasonal patterns of myositis autoantibodiesBoaz Palterer, Alessio Mazzoni, Maria Infantino, et al.
The Journal of Clinical Investigation|May 29, 2020
Impaired immune cell cytotoxicity in severe COVID-19 is IL-6 dependentAlessio Mazzoni, Lorenzo Salvati, Laura Maggi, et al.
Pageof 8